Description: Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the research, development, and marketing of pharmaceutical, over the counter, and personal care products in Mexico, the United States, and Latin America. It offers antibacterial products under the Next-AB brand name, including disinfecting wet wipes, alcohol-based hand sanitizers, and antibacterial soaps; razor products under the Groomen brand; anti-flu medicines under the Next brand; HIV testing kits under the OraQuick brand name; and isotonic beverages under the Suerox brand, as well as gold lift creams under the Cicatricure brand. The company also provides shampoos under the Revie, Vanart, and Tío Nacho names; and cough and cold medicines under the Tukol brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.
Home Page: www.genommalab.com
Av. Antonio Dovalí Jaime no.70
Mexico City,
DF
01210
Mexico
Phone:
52 55 5081 0000
Officers
| Name | Title |
|---|---|
| Mr. Jorge Luis Brake Valderrama | Chief Exec. Officer |
| Engineer Antonio Zamora Galland | Exec. VP of Fin. & Admin. and CFO |
| Mr. Juan Marco Sparvieri | Exec. VP & COO |
| Daniel Suarez Neria | Head of Investor Relations |
| Lic. Ruben Alberto Luna Porres | Legal Officer |
| Marianne Blancas Velasco | Global Director of HR |
| Mr. Alejandro Bastón Patiño | Exec. VP of Institutional Relations, Media, HR & Sustainability |
| Mr. Efraín Tapia Córdova | Deputy Sec. |
| Mr. Máximo Juda | Advisor |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 7.6923 |
|---|---|
| Trailing PE: | 11.9571 |
| Price-to-Book MRQ: | 1.3781 |
| Price-to-Sales TTM: | 0.0526 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2297 |